The University of Rochester Medical Center (URMC) and Temple University School of Pharmacy have joined hands to develop new drugs to fight against a range of diseases.
Subscribe to our email newsletter
The tie up allows the scientists of the two institutions to work together and take forward these discoveries to the next stage of research by identifying compounds that act upon these new targets and may ultimately form the basis for new therapeutics.
Under the agreement, the URMC scientists expects to work with Moulder Center’s medicinal chemistry and other drug development capabilities to screen numbers of compounds to identify novel drug candidates that can undergo a battery of pre-clinical tests in the lab and in animal models necessary to ensure that they are stable, not toxic, and act as intended.
Temple University’s Moulder Center for Drug Discovery Research director Magid Abou-Gharbia said the two organizations bring complementary experience and skills to the table and the combination of the two will undoubtedly lead to many new drug discovery projects and increase the chances of identifying new drugs for treating unmet medical needs.